Pugliano C, Berger M, Ray R, Sapkos K, Wu B, Laird A
Mol Ther Methods Clin Dev. 2025; 32(3):101297.
PMID: 40012884
PMC: 11863497.
DOI: 10.1016/j.omtm.2024.101297.
David P, Kouhestani D, Hansen F, Paul S, Czubayko F, Karabiber A
Int J Mol Sci. 2025; 26(4).
PMID: 40003965
PMC: 11854914.
DOI: 10.3390/ijms26041500.
Shu J, Li G, Shu J, Feng H, He Y
Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852152
PMC: 11763752.
DOI: 10.3390/cimb47010037.
Anwar I, DeLaura I, Ladowski J, Schiliro D, Gao Q, Manook M
Sci Transl Med. 2025; 17(779):eadn8130.
PMID: 39742504
PMC: 11797747.
DOI: 10.1126/scitranslmed.adn8130.
Yang N, Li C, Liu R, Qi X, Qian X
Medicine (Baltimore). 2024; 103(43):e40254.
PMID: 39470507
PMC: 11521033.
DOI: 10.1097/MD.0000000000040254.
Implications of CD154 and Its Receptors in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
Allard C, Salti S, Mourad W, Hassan G
Cells. 2024; 13(19.
PMID: 39404385
PMC: 11482534.
DOI: 10.3390/cells13191621.
Consensus, debate, and prospective on pancreatic cancer treatments.
Wang J, Yang J, Narang A, He J, Wolfgang C, Li K
J Hematol Oncol. 2024; 17(1):92.
PMID: 39390609
PMC: 11468220.
DOI: 10.1186/s13045-024-01613-x.
Interleukin 6 and cancer resistance in glioblastoma multiforme.
Detchou D, Barrie U
Neurosurg Rev. 2024; 47(1):541.
PMID: 39231832
DOI: 10.1007/s10143-024-02783-5.
The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets.
Lorestani P, Dashti M, Nejati N, Habibi M, Askari M, Robat-Jazi B
Discov Oncol. 2024; 15(1):369.
PMID: 39186144
PMC: 11347554.
DOI: 10.1007/s12672-024-01256-x.
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial.
St Clair E, Baer A, Ng W, Noaiseh G, Baldini C, Tarrant T
Nat Med. 2024; 30(6):1583-1592.
PMID: 38839899
PMC: 11186761.
DOI: 10.1038/s41591-024-03009-3.
The shared circulating diagnostic biomarkers and molecular mechanisms of systemic lupus erythematosus and inflammatory bowel disease.
Sun H, Zhang X, Shen C
Front Immunol. 2024; 15:1354348.
PMID: 38774864
PMC: 11106441.
DOI: 10.3389/fimmu.2024.1354348.
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A, Pedersen J, Kowatsch M, Scholte F, Lafrance M, Azizi H
Vaccines (Basel). 2024; 12(4).
PMID: 38675751
PMC: 11053682.
DOI: 10.3390/vaccines12040369.
Pan-Cancer Analysis of the Prognostic and Immunological Role of TOMM40 to Identify Its Function in Breast Cancer.
Zhou Y, Wei X, Jia L, Li W, Zhang S, Zhao Y
Biochem Genet. 2024; .
PMID: 38649557
DOI: 10.1007/s10528-024-10794-6.
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling.
Naseri S, Cordova M, Wenthe J, Lovgren T, Eriksson E, Loskog A
J Cell Mol Med. 2024; 28(7):e18162.
PMID: 38494863
PMC: 10945091.
DOI: 10.1111/jcmm.18162.
Causal relationship between the immune phenotype of monocytes and myasthenia gravis: A Mendelian randomization study.
Dong J, Duan R, Zhang P
Heliyon. 2024; 10(5):e26741.
PMID: 38449651
PMC: 10915380.
DOI: 10.1016/j.heliyon.2024.e26741.
Systemic immune response to a CD40 agonist antibody in nonhuman primates.
Caudell D, Dugan G, Babitzki G, Schubert C, Braendli-Baiocco A, Wasserman K
J Leukoc Biol. 2024; 115(6):1084-1093.
PMID: 38372596
PMC: 11626834.
DOI: 10.1093/jleuko/qiae031.
A machine learning algorithm for peripheral artery disease prognosis using biomarker data.
Li B, Shaikh F, Zamzam A, Syed M, Abdin R, Qadura M
iScience. 2024; 27(3):109081.
PMID: 38361633
PMC: 10867451.
DOI: 10.1016/j.isci.2024.109081.
Predictive value of soluble CD40L combined with APACHE II score in elderly patients with sepsis in the emergency department.
Yang L, Yang J, Zhang X, Ye X, Liu Y, Wei B
BMC Anesthesiol. 2024; 24(1):32.
PMID: 38243164
PMC: 10797713.
DOI: 10.1186/s12871-023-02381-w.
Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis.
Golfinopoulou R, Giudicelli V, Manso T, Kossida S
Vaccines (Basel). 2023; 11(12).
PMID: 38140161
PMC: 10747390.
DOI: 10.3390/vaccines11121756.
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
Dharmapuri S, Ozbek U, Jethra H, Jun T, Marron T, Saeed A
World J Gastrointest Oncol. 2023; 15(11):1900-1912.
PMID: 38077640
PMC: 10701235.
DOI: 10.4251/wjgo.v15.i11.1900.